Edition:
India

JSR Corp (4185.T)

4185.T on Tokyo Stock Exchange

2,321JPY
3 Aug 2020
Change (% chg)

-- (--)
Prev Close
¥2,321
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,209,950
52-wk High
¥2,346
52-wk Low
¥1,452

Latest Key Developments (Source: Significant Developments)

JSR Corp Says Will Establish A Wholly-Owned Subsidiary For Investment To Accelerate New Business Development Around Digital Technologies
Wednesday, 21 Aug 2019 

Aug 20 (Reuters) - JSR Corp <4185.T>::JSR CORP - WILL ESTABLISH A WHOLLY-OWNED SUBSIDIARY FOR INVESTMENT TO ACCELERATE NEW BUSINESS DEVELOPMENT AROUND DIGITAL TECHNOLOGIES.JSR CORP - JSR ACTIVE INNOVATION FUND, LLC, TO LAUNCH ON OCT 1, 2019 & WILL INVEST GLOBALLY IN START-UP COMPANIES MAINLY FOCUSING ON DIGITAL TECHNOLOGY.JSR CORP - INVESTMENT BY JSR ACTIVE INNOVATION FUND LLC WILL BEGIN WITH INITIAL ROUND OF 3 BILLION YEN AND IS EXPECTED TO GROW UP TO 10 BILLION YEN.  Full Article

JSR To Buy Back Up To 2.83 Percent Of Shares Worth 10 Billion Yen Through Sept 30
Wednesday, 24 Apr 2019 

April 24 (Reuters) - JSR Corp <4185.T>::TO BUY BACK UP TO 2.83 PERCENT OF SHARES WORTH 10 BILLION YEN THROUGH SEPT 30.  Full Article

JSR's Managing Officer Eric Johnson To Become CEO In June
Thursday, 14 Mar 2019 

March 14 (Reuters) - Japan's JSR Corp <4185.T>::MANAGING OFFICER ERIC JOHNSON TO BECOME CEO IN JUNE.CHANGING TOP MANAGEMENT STRUCTURE TO CREATE POSITIONS OF CEO AND COO.CHANGES AIMED AT IMPLEMENTING MANAGEMENT SYSTEM FROM BROADER PERSPECTIVE AS GLOBAL ECONOMY CONTINUES TO EXPAND AND BECOME MORE DIVERSE.  Full Article

Selexis Expands Strategic Immuno-Oncology Alliance With Agenus
Wednesday, 9 Jan 2019 

Jan 9 (Reuters) - Selexis SA::SELEXIS EXPANDS STRATEGIC IMMUNO-ONCOLOGY ALLIANCE WITH AGENUS.SELEXIS SA SAYS HAS SIGNED ADDITIONAL COMMERCIAL LICENSE AGREEMENTS WITH AGENUS.SELEXIS SA SAYS UNDER NEW LICENSE AGREEMENTS, AGENUS WILL LEVERAGE SELEXIS' MODULAR SURETECHNOLOGY PLATFORM FOR PRODUCTION OF ITS THERAPEUTIC PROTEINS.  Full Article

Medical&Biological Laboratories to offer early-retirement program
Friday, 28 Sep 2018 

Sept 28(Reuters) - Medical&Biological Laboratories Co Ltd <4557.T>:Says it plans to offer an early-retirement program to employees, who are above 40 years old as of Oct. 1.Offering period from Nov. 1 to Nov. 15.The company expects 30 employees to take the offer.Says the employees who take up the offer will retire on Dec. 31.The company will provide retirement payment and outplacement support to the retiring employees.  Full Article

Deals of the day-Mergers and acquisitions

March 30 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday: